Just – Evotec Biologics Expands Contract With Department of Defense For Manufacturing of Monoclonal Antibodies
Just – Evotec Biologics will manufacture anti-SARS-CoV-2 and other antibodies at its J.POD® manufacturing facility. Access to manufacturing capacity over a period of 7 years